Form 8-K - Current report:
SEC Accession No. 0001213900-24-107459
Filing Date
2024-12-10
Accepted
2024-12-10 16:41:18
Documents
16
Period of Report
2024-12-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0224296-8k_klotho.htm   iXBRL 8-K 45075
2 PURCHASE AGREEMENT ea022429601ex4-1_klotho.htm EX-4.1 151409
3 NOTE ea022429601ex4-2_klotho.htm EX-4.2 85431
  Complete submission text file 0001213900-24-107459.txt   559895

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE klto-20241204.xsd EX-101.SCH 3497
5 XBRL DEFINITION FILE klto-20241204_def.xml EX-101.DEF 26516
6 XBRL LABEL FILE klto-20241204_lab.xml EX-101.LAB 36424
7 XBRL PRESENTATION FILE klto-20241204_pre.xml EX-101.PRE 25140
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0224296-8k_klotho_htm.xml XML 5482
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
Klotho Neurosciences, Inc. (Filer) CIK: 0001907223 (see all company filings)

EIN.: 862727441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41340 | Film No.: 241539079
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)